HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $1.3M of Halozyme Therapeutics, Inc.
Sold$1,304,820
$43.49Price
30,000Shares
−5%Stake
What HALO did after the filing
- The stock from Fri, Aug 18 open, $42.17
- −10.6%
- S&P 500, same days
- −1.1%
Measured over 30 trading days, to the Oct 2 close.
Traded Tue, Aug 15. Filed Thu, Aug 17, 5:29 PM ET, after the close. Returns use the Aug 18 open and the Oct 2 close. Not investment advice.